Ms Lynn Sheppard, NP | |
4205 Westbrook Dr, Aurora, IL 60504-4124 | |
(630) 456-7138 | |
Not Available |
Full Name | Ms Lynn Sheppard |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 10 Years |
Location | 4205 Westbrook Dr, Aurora, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134521115 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 041.353801 (Illinois) | Secondary |
363L00000X | Nurse Practitioner | 209.011873 (Illinois) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Entity Name | Advocate Health And Hospitals Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Entity Name | Edward Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013969013 PECOS PAC ID: 0042108110 Enrollment ID: O20040309001279 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Entity Name | Dupage Medical Group Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20040412001479 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Entity Name | Alexian Brothers Specialty Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720371669 PECOS PAC ID: 0840465084 Enrollment ID: O20111216000081 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Lynn Sheppard, NP Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Ms Lynn Sheppard, NP 4205 Westbrook Dr, Aurora, IL 60504-4124 Ph: (630) 456-7138 |
News Archive
An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A new study by researchers at UCLA and Brigham and Women's Hospital in Boston suggests that improvements in air quality over the past decade have resulted in fewer cases of ear infections in children.
The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.
› Verified 6 days ago
Courtney Harley, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2720 E New York St, Ste 108, Aurora, IL 60502 Phone: 630-820-7045 Fax: 630-820-7047 | |
Tochi Okwueze, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Heidijo Elyea, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1256 Waterford Drive, Suite 120, Aurora, IL 60504 Phone: 630-499-6688 Fax: 630-499-6689 | |
Mrs. Haley S.v. Murphy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Ms. Carole Wolfson, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 581 Sullivan Rd Ste B, Aurora, IL 60506 Phone: 630-859-3877 Fax: 630-859-8920 | |
Ms. Kenisha Francisco, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Terra L Kolacki, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 444 N Eola Rd Ste 110, Aurora, IL 60502 Phone: 630-692-5660 Fax: 630-692-5661 |